-
1Academic Journal
Authors: H.V. Palahuta, O.Ye. Fartushna
Source: INTERNATIONAL NEUROLOGICAL JOURNAL; Vol. 16 No. 8 (2020); 43-47
МЕЖДУНАРОДНЫЙ НЕВРОЛОГИЧЕСКИЙ ЖУРНАЛ; Том 16 № 8 (2020); 43-47
МІЖНАРОДНИЙ НЕВРОЛОГІЧНИЙ ЖУРНАЛ; Том 16 № 8 (2020); 43-47Subject Terms: магнітно-резонансна томографія м'язів, specific patterns of muscle damage, limb-girdle muscular dystrophy, magnetic resonance imaging of muscles, конечностно-поясная мышечная дистрофия, кінцівково-поясна м'язова дистрофія, магнитно-резонансная томография мышц, 3. Good health, 03 medical and health sciences, специ-фические паттерны поражения мышц, 0302 clinical medicine, генетика, genetics, специфічні патерни ураження м'язів
File Description: application/pdf
Access URL: http://inj.zaslavsky.com.ua/article/download/221960/223983
http://inj.zaslavsky.com.ua/article/view/221960
https://cyberleninka.ru/article/n/the-role-of-magnetic-resonance-imaging-of-muscles-in-the-differential-diagnosis-of-certain-forms-and-subtypes-of-limb-girdle
http://inj.zaslavsky.com.ua/article/view/221960 -
2Academic Journal
Authors: D. A. Grishina, N. A. Suponeva, V. V. Shvedkov, A. V. Belopasova, Д. А. Гришина, Н. А. Супонева, В. В. Шведков, А. В. Белопасова
Source: Neuromuscular Diseases; Том 5, № 1 (2015); 25-34 ; Нервно-мышечные болезни; Том 5, № 1 (2015); 25-34 ; 2413-0443 ; 2222-8721 ; 10.17650/2222-8721-2015-5-1
Subject Terms: дифференциальный диагноз, calpainopathy, calpain 3, inherited myopathy, creatinine phosphokinase, electromyography, muscle magnetic resonance imaging, genetic analysis, muscle biopsy, differential diagnosis, кальпаинопатия, кальпаин-3, наследственная миопатия, креатининфосфокиназа, электромиография, магнитно-резонансная томография мышц, генетический анализ, биопсия мышц
File Description: application/pdf
Relation: https://nmb.abvpress.ru/jour/article/view/107/101; Nigro V., Savarese M. Genetic basis of limbgirdle muscular dystrophies: the 2014 update. Acta Myol 2014;33(1):1–12.; Fanin M., Nardetto L., Nascimbeni A. et al. Correlations between clinical severity, genotype and muscle pathology in limb girdle muscular dystrophy type 2A. J Med Genet 2007;44:609–14.; Moore S., Shilling C., Westra S. et al. Limbgirdle muscular dystrophy in the United States. J Neuropathol Exp Neurol 2006;65(10):995–1003.; Duno M., Sveen M., Schwartz M., Vissing J. cDNA analyses of CAPN3 enhance mutation detection and reveal a low prevalence of LGMD2A patients in Denmark. Eur J Hum Genet 2008;16(8):935–40.; Van der Kooi A., Frankhuizen W., Barth P. et al. Limb-girdle muscular dystrophy in the Netherlands: gene defect identified in half the families. Neurology 2007;68:2125–8.; Guglieri M., Magri F., D'Angelo M. et al. Clinical, molecular, and protein correlations in a large sample of genetically diagnosed Italian limb girdle muscular dystrophy patients. Hum Mut 2008;29(2):258–66.; Minami N., Nishino I., Kobayashi O. et al. Mutations of calpain 3 gene in patients with sporadic limb-girdle muscular dystrophy in Japan. J Neurol Sci 1999;171(1):31–7.; Dincer P., Leturcq F., Richard I. et al. A biochemical, genetic, and clinical survey of autosomal recessive limb girdle muscular dystrophies in Turkey. Ann Neurol 1997;42(2):222–9.; Pathak P., Sharma M., Sarkar C. et al. Limbgirdle muscular dystrophy type 2A in India: a study based on semi-quantitative protein analysis, with clinical and histopathological correlation. Neurol India 2010;58:549–54.; Рыжкова О.П. Клинико-молекулярно генетический анализ изолированных поясно-конечностных мышечных дистрофий, являющихся ферментопатиями. Автореф. дис. . канд. мед. наук. 2011. [Ryzhkova O.P. Clinical and molecular-genetic analysis of isolated limb-girdle muscular dystrophy, which fermentopathia. Aftoref. ref. dis …. CMSci. 2011].; Fardeau M., Hillaire D., Mignard C. et al. Clinical, histopathological and genetic data from a small community living in the Reunion Island. Brain 1996;119:295–308.; Zatz M., de Paula F., Starling A., Vainzof M. The 10 autosomal recessive limbgirdle muscular dystrophies. Neuromusc Disord 2003;13(7–8):532–44.; Allamand V., Broux O., Bourq N. et al. Genetic heterogeneity of autosomal recessive limb-girdle muscular dystrophy in a genetic isolate (Amish) and evidence for a new locus. Hum Mol Genet 1995;4(3):459–63.; Urtasun M., Saenz A., Roudaut C. et al. Limb-girdle muscular dystrophy in Guipuzcoa (Basque Country, Spain). Brain 1998;121:1735–47.; Ono Y., Shimada H., Sorimachi H. et al. Functional defects of a muscle-specific calpain, p94, caused by mutations associated with limb-girdle muscular dystrophy type 2A. J Biol Chem 1998;273:17073–8.; Keira Y., Noguchi S., Minami N. et al. Localization of calpain 3 in human skeletal muscle and its alteration in limb-girdle muscular dystrophy 2A muscle. J Biochem 2003;133:659–64.; Канцерова Н.П., Лысенко Л.А., Немова Н.Н. Особенности структуры и свойств внутриклеточных кальцийактивируемых протеиназ у беспозвоночных животных. Современные проблемы физиологии и биохимии водных организмов. Т. I. Экологическая физиология и биохимия водных организмов. Сборник научных статей. Петрозаводск: КарНЦ РАН, 2010. C. 68–73. [Kantserova N.P., Lysenko L.A., Nemova N.N. Structure and properties of intracellular CA-activated proteases in invertebrate animals. Modern problems of physiology and biochemistry of aquatic organisms. I. Ecological physiology and biochemistry of aquatic organisms. The collection of scientific articles. Petrozavodsk: KarRC RAS, 2010; p. 68–73 (In Russ.)].; Branca D. Calpain-related diseases. Biochem Biophys Res Commun 2004;322:1098–104.; Ferreira A. Calpain Dysregulation in Alzheimer’s Disease. Biochemistry. 2012, ID 728571, 12 p.; Richard I., Roudaut C., Saenz A. et al. Calpainopathy-a survey of mutations and polymorphisms. Am J Hum Genet 1999;64:1524–40.; Kramerova I., Beckmann J., Spencer M. Molecular and cellular basis of calpainopathy (limb girdle muscular dystrophy type 2A). Biochim Biophys Acta 2007;1772:128–44.; Todorova A., Georgieva B., Tournev I. et al. A large deletion and novel point mutations in the calpain 3 gene (CAPN3) in Bulgarian LGMD2A patients.Neurogenetics 2007;8:225–9.; Dadali E., Shagina O., Ryzhkova O. et al. Clinical-genetic characteristics of limb girdlemuscular dystrophy type 2A. Zh Neurol Psikhiatr Im S S Korsakova. 2010;110(4): 79–83.; Pogoda T., Krakhmaleva I., Lipatova N. et al. High incidence of 550delA mutation of CAPN3 in LGMD2 patients from Russia. Hum Mut 2000;15:295.; Ojima K., Ono Y., Hata S. et al. Possible functions of p94 in connectin-mediated signaling pathways in skeletal muscle cells. J Muscle Res Cell Motil 2005;26(6–8):409–17.; Kramerova I., Kudryashova E., Venkatraman G., Spencer M. Calpain 3 participates in sarcomere remodeling by acting upstream of the ubiquitin-proteasome pathway. Hum Mol Genet 2005;14:2125–34.; Duguez S., Bartoli M., Richard I. Calpain 3: a key regulator of the sarcomere? FEBS J 2006; 273:3427–36.; Baghdiguian S., Richard I., Martin M.et al. Pathophysiology of limb girdle muscular dystrophy type 2A: hypothesis and new insights into the IkappaBalpha/NF-kappaB survival pathway in skeletal muscle. J Mol Med 2001;79:254–61.; Hauerslev S., Sveen M., Duno M. et al. Calpain 3 is important for muscle regeneration: evidence from patients with limb girdle muscular dystrophies. BMC Musculoskelet Disord 2012;13:43.; Bansal D., Campbell K. Dysferlin and the plasma membrane repair in muscular dystrophy. Trends Cell Biol 2004;14:206–13.; Anderson L., Harrison R., Pogue R. et al. Secondary reduction in calpain 3 expression in patients with limb girdle muscular dystrophy type 2B and Miyoshi myopathy (primary dysferlinopathies). Neuromuscul Dis 2000;10:553–9.; Sorimachi H., Ono Y., Suzuki K. Skeletal muscle-specific calpain, p94, and connectin/titin: their physiological functions and relationship to limb-girdle muscular dystrophy type 2A. Adv Exp Med Biol 2000;481:383–95.; Haravuori H., Vihola A., Straub V. et al. Secondary calpain3 deficiency in 2q-linked muscular dystrophy: titin is the candidate gene. Neurology 2001;56:869–77.; Ermolova N., Kudryashova E., Di Franco M. et al. Pathogenity of some limb girdle muscular dystrophy mutations can result from reduced anchorage to myofibrils and altered stability of calpain 3. Hum Mol Genet 2011;20:3331–45.; Rajakumar D., Alexander M., Oommen A. Oxidative stress, NF-κB and the ubiquitin proteasomal pathway in the pathology of calpainopathy. Neurochem Res 2013;38(10):2009–18.; Benayoun B., Baghdiguian S., Lajmanovich A. et al. NF-kappaB-dependent expression of the antiapoptotic factor c-FLIP is regulated by calpain 3, the protein involved in limb-girdle muscular dystrophy type 2A. FASEB J 2008;22:1521–9.; Kramerova I., Kudryashova E., Wu B. et al. Novel role of calpain-3 in the triad-associated protein complex regulating calcium release in skeletal muscle. Hum Mol Genet 2008;17:3271–80.; Fanin M., Nascimbeni A., Aurino S. et al. Frequency of LGMD gene mutations in Italian patients with distinct clinical phenotypes. Neurology 2009b;72:1432–5.; Kyriakides T., Angelini C., Schaefer J. et al. EFNS guidelines on the diagnostic approach to pauci- or asymptomatic hyperCKemia. Eur J Neurol 2010;17:767–73.; Pollitt C., Anderson L., Pogue R. et al. The phenotype of calpainopathy: diagnosis based on a multidisciplinary approach. Neuromusc Disord 2001;11:287–96.; Sáenz A., Leturcq F., Cobo A. et al. LGMD2A: genotype-phenotype correlations based on a large mutational survey on the calpain 3 gene. Brain 2005;128:732–42.; Касаткина Л.Ф., Гильванова О.В. Электромиографические методы исследования в диагностике нервно-мышечных заболеваний. Игольчатая электромиография. Медика,2010; с. 416. [Kasatkina L.F., Gilvanova O.V. Electromyographic research methods in the diagnosis of neuromuscular diseases. Needle electromyography. Medica; p. 416. (In Russ.)].; Mercuri E., Bushby K., Ricci E. et al. Muscle MRI findings in patients with limb girdle muscular dystrophy with calpain 3deficiency (LGMD2A) and early contractures. Neuromusc Disord 2005;15:164–71.; Fischer D., Walter M., Kesper K. et al. Diagnostic value of muscle MRI in differentiating LGMD2I from other LGMDs. J Neurol 2005;252:538–47.; Robert Carlier. МРТ мышц/МРТ всего тела в диагностике и динамическом наблюдении пациентов с нервно-мышечными заболеваниями. Нервно-мышечные болезни 2014;2;16–26. [Robert Carlier. MNM et IRM Musculaire/corps entier: apport au diagnostic et au suivi. Nervno-mishechnie bolezni = Neuromuscular disease journal 2014;2:16–24 (In Russ.)].; Chae J., Minami N., Jin Y. et al. Calpain 3 gene mutations: genetic and clinico-pathologic findings in limb-girdle muscular dystrophy Neuromuscul Dis 2001; 11:547–55.; Fanin M., Nascimbeni A., Fulizio L. et al. Loss of calpain-3 autocatalytic activity in LGMD2A patients with normal protein expression Am J Pathol 2003;163: 1929–36.; Hermanova M., Zapletalova E., Sedlackova J. et al. Analysis of histopathologic and molecular pathologic findings in Czech LGMD2A patients. Muscle Nerve 2006;33:424–32.; Sáenz A., Azpitarte M., Armananzas R. et al. Gene expression profiling in limb girdle muscular dystrophy 2A. PLoS One 2008;3:e3750.; Hauerslev S., Sveen M., Duno M. et al. Calpain 3 is important for muscle regeneration: evidence from patients with limb girdle muscular dystrophies. BMC Musculoskelet Disordm2012;13:43.; Kolski H., Hawkins C., Zatz M. et al. Diagnosis of limb-girdle muscular dystrophy 2A by immunohistochemistry techniques. Neuropathology 2008;28:264–8.; Charlton R., Henderson M., Richards J. et al. Immunohistochemical analysis of calpain 3: advantages and limitations in diagnosing LGMD2A. Neuromusc Disord 2009;19: 449–57.; Haravuori H., Vihola A., Straub V. et al. Secondary calpain3 deficiency in 2q-linked muscular dystrophy: titin is the candidate gene. Neurology. 2001;56:869–77.; Рыжкова О.П., Дадали Е.Л., Щагина О.А. и др. Алгоритмы клинико-молекулярно-генетической диагностики наследственных прогрессирующих мышечных дистрофий. Медицинская генетика. 2011;2:17–23. [Ryzhkova O.P., Dadaly E.L., Schagina O.A. et al. Clinical, molecular and genetic diagnostic algorithms of hereditary progressive muscular dystrophy. Medicinskaya genetika = Medical genetics 2011;2:17–23 (In Russ.)].; Andoni Urtizberea J. Дисферлинопатии: проблема за пределами дистальных миопатий. Нервно-мышечные болезни 2012;2;20–8. J. [Andoni Urtizberea J. Dysferlinopathy: the problem outside of distal myopathies. Nervno-mishechnie bolezni = Neuromuscular disease journal 2012;2;20–8 (In Russ.)].; Tawil R., Van Der Maarel S. Facioscapulohumeral muscular dystrophy. Muscle Nerve. 2006;34:1–1.; Nowak K., Davies K. Duchenne muscular dystrophy and dystrophin: pathogenesis and opportunities for treatment. EMBO Rep 2004;5:872–6.; Milone M., Wong L. Diagnosis of mitochondrial myopathies. Mol Genet Metab 2013;110(1–2):35-41.; Claude Desnuelle. Поздняя форма болезни Помпе: диагностические и терапевтические подходы. Нервно-мышечные болезни 2012;(3):20–32. [Claude Desnuelle. Late-onset Pómpe disease: diagnostic and therapeutic approache. Nervno-mishechnie bolezni = Neuromuscular disease journal 2012;(3):20–32 (In Russ.)].; Walter M., Reilich P., Thiele S. et al. Treatment of dysferlinopathy with deflazacort: a double-blind, placebocontrolled clinical trial. Orphanet J Rare Dis 2013;14;8:26.; Bartoli M., Roudaut C., Martin S. et al. Safety and efficacy of AAV-mediated calpain 3 gene transfer in a mouse model of limb-girdle muscular dystrophy type 2A. Mol Ther 2006;13:250–9; https://nmb.abvpress.ru/jour/article/view/107
-
3Academic Journal
Authors: N. A. Shnayder, T. Ya. Nikolayeva, E. N. Boroeva, G. M. Pshennikova, N. V. Luginov, Yu. S. Panina, Н. А. Шнайдер, Т. Я. Николаева, Е. Н. Бороева, Г. М. Пшенникова, Н. В. Лугинов, Ю. С. Панина
Source: Neuromuscular Diseases; № 1 (2013); 46-61 ; Нервно-мышечные болезни; № 1 (2013); 46-61 ; 2413-0443 ; 2222-8721 ; 10.17650/2222-8721-2013-0-1
Subject Terms: магнитно-резонансная томография мышц, Erb's muscular dystrophy, limb-girdle muscular dystrophy, progressive muscular dystrophy, myotilinopathy, laminopathy, caveolinopathy, human genetics, cardiomyopathy, muscle magnetic resonance imaging, мышечная дистрофия Эрба, конечностно-поясная мышечная дистрофия, прогрессирующая мышечная дистрофия, миотилинопатия, ламинопатия, кавеолинопатия, генетика человека, кардиомиопатия
File Description: application/pdf
Relation: https://nmb.abvpress.ru/jour/article/view/40/36; Bushby K.M. Diagnosis and management of the limb girdle muscular dystrophies. Pract Neurol 2009;9:314–23.; Guglieri M., Straub V., Bushby K., Lochmüller H. Limb-girdle muscular dystrophies. Curr Opin Neurol ;21(5):576–84.; Campbell K.P. Loss of three muscular dystrophies: disruption of cytoskeletonextracellular matrix linkage. Cell 1995;80:675–9.; Angelini C., Fanin M., Freda P. et al. The clinical spectrum of sarcoglycanopathies. Neurology 1999;52:176–9.; Carbone I., Bruno C., Sotgia F. et al. Mutation in the CAV3 gene causes partial caveolin-3 deficiency and hyperCKemia. Neurology 2000;54:1373–6.; Bansal D., Miyake K., Vogel S.S. et al. Defective membrane repair in dysferlindeficient muscular dystrophy. Nature 2003;423(6936):168–72.; Branca D. Calpain-related diseases. Biochem Biophys Res Commun 2004;322(4):1098–104.; Ferreiro A., Mezmezian M., Olivé M. et al. Telethonin-deficiency initially presenting as a congenital muscular dystrophy. Neuromuscul Disord 2011;21(6):433–8.; Garvey S.M., Liu Y., Miller S.E., Hauser M.A. Myotilin overexpression enhances myopathology in the LGMD1A mouse model. Muscle Nerve 2008;37(5):663–7.; Hackman P., Vihola A., Haravuori H. et al. Tibial muscular dystrophy is a titinopathy caused by mutations in TTN, the gene encoding the giant skeletal-muscle protein titin. Am J Hum Genet 2002;71(3):492–500.; Astejada M.N., Goto K., Nagano A. et al. Emerinopathy and laminopathy clinical, pathological and molecular features of muscular dystrophy with nuclear envelopathy in Japan. Acta Myol 2007;26(3):159–64.; Antoniades L., Eftychiou C., Kyriakides T. et al. Malignant mutation in the lamin A/C gene causing progressive conduction system disease and early sudden death in a family with mild form of limbgirdle muscular dystrophy. J Interv Card Electrophysiol 2007;19(1):1–7.; Meryon E. On granular and fatty degeneration of the voluntary muscle. Med Chir Trans 1852:73–85.; Leyden E. Klinik der Rukenmarkskrankheiten. Vol. 2. Berlin: Verlag A. Hirschwald, 1876:525–40.; Mobius P.J. Uber die hereditaren nervenkrankheiten. Volkmanns Samml Klin 1879;171:1501–31.; Erb W. Uber die "juvenile form" der progressiven Muskelatrophie und ihre Beziehungen zur sogenannten Pseudohypertrophie des Muskeln. Dtsch Arch Klin Med 1884;34:467–519.; Erb W. Dystrophia muscularis progressiva. Klinische und pathologischanatomische Studien. Dtsch Z Nervenheit 1891;1:13–94,173–261.; Nevin S. Two cases of muscular degeneration occurring in late adult life, with a review of the recorded cases of late progressive muscular dystrophy (late progressive myopathy). Q J Med 1936;17:51–68.; Levison H. Dystrophia musculorum progressiva. Clinical and diagnostic criteria, inheritance. Acta Psychiatry Scand 1951;76:7–176.; Stevenson A.C. Muscular dystrophy in northern Ireland. I. An account of the condition in fifty-one families. Ann Eugen (London) 1953;18:50–93.; Stevenson A.C. Muscular dystrophy in northern Ireland. II. An account of nine additional families. Ann Hum Genet 1955;19:15964.; Walton J.N., Nattrass F.J. On the classification, natural history and treatment of the myopathies. Brain 1954;77:170–231.; Bradley W.G. The limb-girdle syndrome. In: Vinken P.J., Bruyn G.W., editors. Handbook of Clinical Neurology. Vol. 40. Diseases of muscle. Part I. Amsterdam: North-Holland Publ, 1979:433–469.; Грознова О.С., Новиков П.В. Ранняя диагностика поражения сердца при Х- сцепленной форме мышечной дистрофии Эмери–Дрейфуса у детей. Рос вестн перинатолог педиатр 2011;(1):63–78.; Bushby K.M. Diagnostic criteria of the limb-girdle muscular dystrophies: report of the ENMC consortium on limb-girdle dystrophies. Neuromuscul Disord 1995; 5:71–4.; Penttilä S., Palmio J., Suominen T. et al. Eight new mutations and the expanding phenotype variability in muscular dystrophy caused by ANO5. Neurology 2012;78:897– 903.; Bushby K.M. The limb-girdle muscular dystrophies-multiple genes, multiple mechanisms. Hum Mol Genet 1999;8:1875–82.; van der Kooi A.J., Frankhuizen W.S., Barth P.G. et al. Limb-girdle muscular dystrophy in the Netherlands: gene defect identified in half the families. Neurology 2007;68(24):2125–8.; Lo H.P., Cooper S.T., Evesson F.J. et al. Limb-girdle muscular dystrophy: diagnostic evaluation, frequency and clues to pathogenesis. Neuromuscul Disord 2008;18(1):34–44.; Stensland E., Lindal S., Jonsrud C. et al. Prevalence, mutation spectrum and phenotypic variability in Norwegian patients with Limb Girdle Muscular Dystrophy 2I. Neuromuscul Disord 2011;21(1):41–6.; Urtasun M., Saenz A., Roudaut C. et al. Limb-girdle muscular dystrophy in Guipuzcoa (Basque Country, Spain). Brain 1998;121(Pt 9):1735–47.; Sveen M.L., Schwartz M., Vissing J. High prevalence and phenotype-genotype correlations of limb girdle muscular dystrophy type 2I in Denmark. Ann Neurol 2006;59(5):808–15.; Kirschner J., Lochmuller H. Sarcoglycanopathies. Handb Clin Neurol 2011;101:41–46.; Nalini A., Gayathri N., Thaha F. et al. Sarcoglycanopathy: clinical and histochemical characteristics in 66 patients. Neurol India 2010;58(5):691–6.; Vainzof M., Passos-Bueno M.R., Pavanello R.C. et al. Sarcoglycanopathies are responsible for 68% of severe autosomal recessive limb-girdle muscular dystrophy in the Brazilian population. J Neurol Sci 1999;164:44–9.; Passos-Bueno M.R., Vainzof M., Moreira E.S., Zatz M. Seven autosomal recessive limbgirdle muscular dystrophies in the Brazilian population: from LGMD2A to LGMD2G. Am J Med Genet 1999;82(5):392–8.; Hackman P., Juvonen V., Sarparanta J. et al. Enrichment of the R77C alphasarcoglycan gene mutation in Finnish LGMD2D patients. Muscle Nerve 2005;31:199–204.; Angelini C., Fanin M., Freda M.P. et al. The clinical spectrum of sarcoglycanopathies. Neurology 1999;52(1):176–9.; Amberger J., Bocchini C., Hamosh A. A new face and new challanges for online Mendelian Inheritance in Man (OMIM®). Hum. Mutat 2011;32:564–7.; Selcen D., Engel A.G. Mutations in myotilin cause myofibrillar myopathy. Neurology 2004;62(8):1363–71.; Дадали Е.Л., Билева Д.С., Угаров И.В. Клинико-генетическая характеристика наследственных ламинопатий. Анн клин эксперим неврол 2008;2(4);28–33.; Руденская Т.Е., Тверская С.М., Чухрова А.Л. и др. Разнообразие болезней, обусловленных мутациями гена LMNA. Мед генет 2004;(12):569–76.; Руденская Т.Е., Поляков А.В., Тверская С.М. и др. Ламинопатии в русских семьях. Мед генет 2008;(2):127–133.; D'Amico A., Benedetti S., Petrini S. et al. Major myofibrillar changes in early onset myopathy due to de novo heterozygous missense mutation in lamin A/C gene. Neuromuscul Disord 2005;15:847–50.; Aboumousa A., Hoogendijk J., Charlton R. et al. Caveolinopathy – new mutations and additional symptoms. Neuromuscul Disord 2008;18(7):572–8.; Fulizio L., Nascimbeni A.C., Fanin M. et al. Molecular and muscle pathology in a series of caveolinopathy patients. Hum Mutat 2005;25(1):82–9.; Hackman P., Sandell S., Sarparanta J. et al. Four new Finnish families with LGMD1D; refinement of the clinical phenotype and the linked 7q36 locus. Neuromuscul Disord 2011;21(5):338–44.; Messina D.N., Speer M.C., Pericak-Vance M.A. et al. Linkage of familial dilated cardiomyopathy with conduction defect and muscular dystrophy to chromosome 6q23. Am J Hum Genet 1997;61(4):909–17.; Palenzuela L., Andreu A.L., Gamez J. et al. A novel autosomal dominant limbgirdle muscular dystrophy (LGMD 1F) maps to 7q32.1-32.2. Neurology 2003;61(3):404–6.; Starling A., Kok F., Passos-Bueno M.R. et al. A new form of autosomal dominant limb-girdle muscular dystrophy (LGMD1G) with progressive fingers and toes flexion limitation maps to chromosome 4p21. Eur J Hum Genet 2004;12(12):1033–40.; Bisceglia L., Zoccolella S., Toracco A. et al. A new locus on 3p23-p25 for an autosomal dominant limb-girdle muscular dystrophy, LGMD1H. Europ J Hum Genet 2010;18:636–41.; Muchir A., Bonne G., van der Kooi A.J. et al. Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B). Hum Mol Genet 2000;9(9):1453–9.; Kramerova I., Beckmann J.S., Spencer M.J. Molecular and cellular basis of calpainopathy (limb girdle muscular dystrophy type 2A). Biochim Biophys Acta 2007;1772(2):128–44.; Mendell J.R., Rodino-Klapac L.R., Rosales X.Q. et al. Sustained alphasarcoglycan gene expression after gene transfer in limb-girdle muscular dystrophy, type 2D. Ann Neurol 2010;68(5):629–38.; Nigro V., de Sa Moreira E., Piluso G. et al. Autosomal recessive limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in the delta-sarcoglycan gene. Nat Genet 1996;14:195–8.; Moreira E.S., Wiltshire T.J., Faulkner G. et al. Limb-girdle muscular dystrophy type 2G is caused by mutations in the gene encoding the sarcomeric protein telethonin. Nat Genet 2000;24:163–6.; Saccone V., Palmieri M., Passamano L. et al. Mutations that impair interaction properties of TRIM32 associated with limbgirdle muscular dystrophy type 2H. Hum. Mutat 2008;29:240–7.; Рыжкова О.П., Шаркова И.В., Дадали Е.Л. и др. Клинико-генетический анализ поясно-конечностной прогрессирующей мышечной дистрофии типа 2I. Журн неврол психиатр 2012;(6):55–9.; Pénisson-Besnier I., Hackman P., Suominen T. et al. Myopathies caused by homozygous titin mutations: limb-girdle muscular dystrophy 2J and variations of phenotype. J Neurol Neurosurg Psychiatry 2010;81(11):1200–2.; Selcen D. Myofibrillar myopathies. Neuromuscul Disord 2011;21(3):161–71.; Дадали Е.Л., Руденская Т.Е., Щагина О.А. и др. Мерозин-дефицитная врожденная мышечная дистрофия (ВМД1А). Журн неврол психиатр 2010;3:83–9.; Bushby K. Diagnosis and management of the limb girdle muscular dystrophies. Pract Neurol 2009;9(6):314–23.; Zhang Y., Huang J.J., Wang Z.Q. et al. Value of muscle enzyme measurement in evaluating different neuromuscular diseases. Clin Chim Acta 2012;413(3–4):520–4.; AdyanT., Ryzkova O., Polyakov A. Limbgirdle muscular dystrophies with autosomal dominant inheritance. Eur J Neurology 2012;19:383–3.; Trabelsi M., Kavian N., Daoud F. et al. Revised spectrum of mutations in sarcoglycanopathies. Eur J Hum Genet 2008;16(7):793–803.; Stramare R., Beltrame V., Dal Borgo R. et al. MRI in the assessment of muscular pathology: a comparison between limbgirdle muscular dystrophies, hyaline body myopathies and myotonic dystrophies. Radiol Med 2010;115(4):585–99.; Fischer D., Walter M.C., Kesper K. Diagnostic value of muscle MRI in differentiating LGMD2I from other LGMDs. J Neurol 2005;252:538–47.; Preston D.C., Shapiro B.E. Needle electromyography. Fundamentals, normal and abnormal patterns. Neurol Clin 2002;20(2):361–96.; Derry K.L., Venance S.L., Doherty T.J. Decomposition-based quantitative electromyography in the evaluation of muscular dystrophy severity. Muscle Nerve 2012;45(4):507–13.; Подагова Е.В., Дадали Е.Л., Мальмберг С.А. и др. Особенности диагностики псевдогипертрофических вариантов поясно-конечностных прогрессирующих мышечных дистрофий. Неврол журн 2007;12(1):24–8.; Poppe M., Bourke J., Eagle M. et al. Cardiac and respiratory failure in limb-girdle muscular dystrophy 2I. Ann Neurol 2004;56:38–41.; Wahbi K., Meune C., Hamouda el H. et al. Cardiac assessment of limb-girdle muscular dystrophy 2I patients: an echography, Holter ECG and magnetic resonance imaging study. Neuromuscul Disord 2008;18(8):650–5.; D'Angelo M.G., Romei M., Lo Mauro A. et al. Respiratory pattern in an adult population of dystrophic patients. J Neurol Sci 2011;306(1–2):54–61.; Stübgen J.P., Ras G.J., Schultz C.M., Crowther G. Lung and respiratory muscle function in limb girdle muscular dystrophy. Thorax 1994;49(1):61–5.; Lacomis D. The utility of muscle biopsy. Curr Neurol Neurosci Rep 2004;4(1):81–6.; Mitsuhashi S., Kang P.B. Update on the genetics of limb girdle muscular dystrophy. Semin Pediatr Neurol 2012;19(4):211–8.; Awater C., Zerres K., Rudnik-Schöneborn S. Pregnancy course and outcome in women with hereditary; neuromuscular disorders: comparison of obstetric risks in 178 patients. Eur J Obstet Gynecol Reprod Biol ;162(2):153–9.; Oygard K., Haestad H., Jørgensen L. Physiotherapy, based on the Bobath concept, may influence the gait pattern in persons with limb-girdle muscle dystrophy: a multiple case series study. Physiother Res Int 2011;16(1):20–31.; Грознова О.С., Тренева М.С. Генетические аспекты возникновения жизнеугрожаемых состояний у больных с миопатией. Рос вестн перинатолог педиатр 2011;56(5):38–41.; Shapiro F., Specht L. The diagnosis and orthopaedic treatment of inherited muscular diseases of childhood. J Bone Joint Surg Am 1993;75(3):439–54.; Eggers S., Zatz M. Social adjustment in adult males affected with progressive muscular dystrophy. Am J Med Genet 1998;81:4–12.; Nishiyama A., Ampong B.N., Ohshima S. et al. Recombinant adenoassociated virus type 8-mediated extensive therapeutic gene delivery into skeletal muscle of alpha-sarcoglycan-deficient mice. Hum Gene Ther 2008;19(7):719–30.; Nigro V., Aurino S., Piluso G. Limb girdle muscular dystrophies: update on genetic diagnosis and therapeutic approaches. Curr Opin Neurol 2011;24(5):429–36.; Norwood F., de Visser M., Eymard B. et al. EFNS Guideline Task Force. EFNS guideline on diagnosis and management of limb girdle muscular dystrophies. Eur J Neurol 2007;14(12):1305–12.; https://nmb.abvpress.ru/jour/article/view/40
-
4Academic Journal
Authors: D. A. Grishina, N. A. Suponeva, V. V. Shvedkov, A. V. Belopasova, Дарья Александровна Гришина, Н. А. Супонева, В. В. Шведков, А. В. Белопасова
Source: Neuromuscular Diseases; Том 5, № 1 (2015); 42-47 ; Нервно-мышечные болезни; Том 5, № 1 (2015); 42-47 ; 2413-0443 ; 2222-8721 ; 10.17650/2222-8721-2015-5-1
Subject Terms: магнитно-резонансная томография мышц, calpainopathy, hereditary myopathy, proximal tetraparesis, creatine phosphate, electromyography, muscle MRI, кальпаинопатия, наследственная миопатия, проксимальный тетрапарез, креатининфосфокиназа, электромиография
File Description: application/pdf
Relation: https://nmb.abvpress.ru/jour/article/view/109/103; Zatz M., de Paula F., Starling A., Vainzof M. The 10 autosomal recessive limb-girdle muscular dystrophies. Neuromusc Disord 2003;13(7–8):532–44.; Дадали E.Л., Щагина O.А., Рыжкова O.П. и др. Клинико-генетические характеристики поясно-конечностной мышечной дистрофии 2A типа. Журн неврол и психиатр им. С.С. Корсакова 2010;110(4):79–83. [Dadali E., Shagina O., Ryzhkova O. et al. Clinical-genetic characteristics of limb girdlemuscular dystrophy type 2A. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova = Journal of neurology and psychiatry them with Korsakov 2010; 110(4):79–83 (In Russ.)].; Sáenz A., Leturcq F., Cobo A. et al. LGMD2A: genotype-phenotype correlations based on a large mutational survey on the calpain 3 gene. Brain 2005;128: 732–42.; Groen E., Charlton R., Barresi R. et al. Analysis of the UK diagnostic strategy for limb girdle muscular dystrophy 2A. Brain 2007;130(12):3237–49.; Mercuri E., Bushby K., Ricci E. et al. Muscle MRI findings in patients with limb girdle muscular dystrophy with calpain 3 deficiency (LGMD2A) and early contractures. Neuromusc Disord 2005;15:164–71.; Рыжкова О.П., Дадали Е.Л., Щагина О.А. и др. Алгоритмы клинико-молекулярно-; генетической диагностики наследственных прогрессирующих мышечных дистрофий. Мед генетика. 2011;2:17–23. [Ryzhkova O.P., Dadaly E.L., Schagina O.A. et al. Clinical; molecular and genetic diagnostic algorithms of hereditary progressive muscular dystrophy.; Medicinskaya genetica = Med genetics 2011;2:17–23 (In Russ.)].; Fanin M., Nardetto L., Nascimbeni A. et al. Correlations between clinical severity; genotype and muscle pathology in limb girdle muscular dystrophy type 2A. J Med Genet 2007;44:609–14.; https://nmb.abvpress.ru/jour/article/view/109